Clinical Trial Update: Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris [Phase 1]

View source ↗

Summary

An update on a Phase 1 trial studying immunogenetic profiling of Goeckerman Therapy for psoriasis vulgaris. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriasis Vulgaris

Snippet

Sponsor: University of California, San Francisco | Conditions: Psoriasis Vulgaris, Psoriasis | Phase 1 | Status: TERMINATED